Effects of IL-13 on murine listeriosis

International Immunology

Volumn 9, Issue 4, 1997, Pages 467-474

  Flesch, Inge E A ^a   Wandersee, Alexandra ^a   Kaufmann, Stefan H E ^a,b  

^a UNIVERSITY OF ULM   (Germany)

^b MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

IL 13; IL 2; IL 4; Listeriosis

Indexed keywords

CYTOKINE; INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 13;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CONTROLLED STUDY; GRANULOMA; HELPER CELL; IMMUNE RESPONSE; IN VITRO STUDY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; BONE MARROW; BONE MARROW CELLS; CYTOKINES; GRANULOMA; IMMUNITY, NATURAL; INTERLEUKIN-13; KILLER CELLS, NATURAL; LISTERIA INFECTIONS; MICE; MICE, INBRED C57BL; RECOMBINANT PROTEINS; SPLEEN;

EID: 0030887782     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.4.467     Document Type: Article

References (33)

1. Brown, K. D., Zurawski, S. M., Mosmann, T. R. and Zurawski, G. 1989. A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. J. Immunol. 142:679.
2. Doyle, A. G., Herbein, G., Montaner, L. J., Minty, A. J., Caput, D., Ferrara, P. and Gordon, S. 1994. Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-γ. Eur. J. Immunol. 24:1441.
3. Doherty, T. M., Kastelein, R., Menon, S., Andrade, S. and Coffman, R. L. 1993. Modulation of murine macrophage function by IL-13. J. Immunol. 151:7151.
4. Zurawski, G. and de Vries, J. E. 1994. Interleukin-13, an interleukin-4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15:19.
5. Kaufmann, S. H. E. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129.
6. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
7. Locksley, R. M. 1993. Interleukin 12 in host defense against microbial pathogens. Proc. Natl Acad. Sci. USA 90:5879.
8. Tripp, C. S., Wolf, S. F. and Unanue, E. R. 1993. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl Acad. Sci. USA 90:3725.
9. Haak-Frendscho, M., Brown, J. F., Iizawa, Y., Wagner, R. D. and Czuprynski, C. J. 1992. Administration of anti-IL-4 monoclonal antibody 11B11 increases the resistance of mice to Listeria monocytogenes infection. J. Immunol. 148:3978.
10. + cells are early IFN-γ producers but impair resistance to Listeria monocytogenes infection. J. Immunol. 152:1873.
11. Burd, P. R., Thompson, W. C., Max, E. E. and Mills, F. C. 1995. Activated mast cells produce interleukin 13. J. Exp. Med. 181:1373.
12. Novitsky, T. J., Roslansky, P. F., Silber, G. R. and Warren, H. S. 1985. Turbidimetric method for quantifying serum inhibition of Limulus amoebocyte lysate. J. Clin. Microbiol. 20:211.
13. Taguchi, T., McGhee, J. R., Coffman, R. L., Beagley, K. W., Eldrige, J. H., Takatsu, K. and Kiyono, H. 1990. Detection of individual mouse splenic T cells producing IFN-γ and IL-5 using the enzyme-linked immunospot (ELISPOT) assay. J. Immunol. Methods 128:65.
14. Flesch, I. and Kaufmann, S. H. E. 1987. Mycobacterial growth inhibition by interferon-γ activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J. Immunol. 138:4408.
15. D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M. and Trinchieri, G. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
16. Mattner, F., Fischer, S., Guckes, S., Jin, S., Kaulen, H., Schmitt, E., Rüde, E. and Germann, T. 1993. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur. J. Immunol. 23:2202.
17. Gillessen, S., Carvajal, D., Ling, P., Podlaski, F. J., Stremlo, D. L., Familletti, P. C., Gubler, U., Presky, D. H., Stern., A. S. and Gately, M. K. 1995. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25:200.
18. Flesch, I. E. A., Hess, J. H., Huang, S., Aguet, M., Rothe, J., Bluethmann, H. and Kaufmann, S. H. E. 1995. Early interleukin-12 production by macrophages in response to mycobacterial infection depends on interferon-γ and tumor necrosis factor-α. J. Exp. Med. 181:1615.
19. Flesch, I. E. A. and Kaufmann, S. H. E. 1995. Differential induction of IL-12 synthesis by Mycobacterium bovis BCG and Listeria monocytogenes. Res. Immunol. 146:520.
20. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.
21. Kawase, I., Brooks, C. G., Kuribayashi, K., Olabuenaga, S., Newman, W., Gillis, S. and Henney, C. S. 1983. Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells. J. Immunol. 131:288.
22. Roder, J. C. 1979. The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function. J. Immunol. 123:2168.
23. Dannenberg, A. M., Jr. 1991. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol. Today 12:228.
24. + cells in acquired immunity. Infect. Immun. 56:1920.
25. Mielke, M. E. A., Rosen, H., Brocke, S., Peters, C. and Hahn, H. 1992. Protective immunity and granuloma formation are mediated by two distinct tumor necrosis factor alpha and gamma interferon-dependent interactions in murine listeriosis: dissociation on the basis of phagocyte adhesion mechanisms. Infect. Immun. 60:1875.
26. Wagner, R. D., Steinberg, H., Brown, J. F. and Czuprynski, C. J. 1994. Recombinant interleukin-12 enhances resistance of mice to Listeria monocytogenes infection. Microbial. Pathogen. 17:175.
27. Wynn, T. A., Cheever, A. W., Jankovic, D., Poindexter, R. W., Caspar, P., Lewis, F. A. and Sher, A. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376:594.
28. Gately, M. K., Warrier, R. R., Honasoge, S., Carvajal, D. M., Faherty, D. A., Connaughton, S. E., Anderson, T. D., Sarmiento, U., Hubbard, B. R. and Murphy, M. 1993. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int. Immnol. 6:157.
29. Hilton, D. J., Zhang, J.-G., Metcalf, D., Alexander, W. S., Nicola, N. A. and Wilson, T. A. 1996. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl Acad. Sci. USA 93:497.
30. Zurawski, S. M., Vega, F., Jr, Huyghe, B. and Zurawski, G. 1993. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 12:2663.
31. Wang, Z.-E., Zheng, S., Corry, D. B., Dalton, D. K., Seder, R. A., Reiner, S. L. and Locksley, R. M. 1994. Interferon-γ-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc. Natl Acad. Sci. USA 91:12932.
32. D'Andrea, A., Ma, X., Aste-Amezaga, M., Paganin, C. and Trinchieri, G. 1995. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor α production. J. Exp. Med. 181:537.
33. Minty, A., Chalon, P., Deroq, J.-M., Dumont, X., Guillemot, J.-C., Kaghad, M., Labit, C., Leplatois, Liauzun, P., Miloux, B., Minty, C., Casellas, P., Loison, G., Lupker, J., Shire, D., Ferrara, P. and Caput, D. 1993. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362:248.